Brief: First Patient Receives Gamida Cell's blood cancer treatment
27/09/2023 23:05
Sept 27 (Reuters) - Gamida Cell Ltd GMDA.O :
* FIRST PATIENT RECEIVES GAMIDA CELL'S OMISIRGE™
(OMIDUBICEL-ONLV)
Source text for Eikon: ID:nBwb7SfMSa
Further company coverage: GMDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gamida Cell
See all newsBrief: Gamida Cell Appoints Joe Wiley As CEO
Brief: Gamida Cell Says District Court Of Beersheba, Israel Entered Judgment In Restructuring Proceeding
Israeli ADRs up on hopes of de-escalation in Israel-Iran tensions
Brief: Aquestive Therapeutics Strengthens Board Of Directors With Experienced Biotech Executive
Brief: Gamida Cell Ltd Says Received Notice From Nasdaq Notifying Co That It Determined Co’S Ordinary Shares Will Be Delisted From Nasdaq